COMP <GO>

DRTS vs AORT // EV/EBITDA & P/E VALUATION

Alpha Tau Medical Ltd. (NASDAQ) VS. Artivion Inc. (NYSE) • 15-METRIC TALLY: DRTS 1 — AORT 4

■ METRIC PARITY

LAST: $13.23 (-0.90%) • MKT CAP: $1.22B

valuation

—

LAST: $23.44 (+2.27%) • MKT CAP: $1.14B

valuation

19.3x

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DRTS VS. AORT) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	DRTS	AORT	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	64.40%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	4.50%	-39.50	AORT	/roic <GO>
EV/EBITDA & P/E Valuation ACTIVE	—	19.3x	—	TIE	/valuation <GO>
Free Cash Flow Yield	-2.68%	0.07%	-2.75	AORT	/fcf-yield <GO>
Operating Margin	—	7.60%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	2.20%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	13.60%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	2.46	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	2/9	9/9	-7.00	AORT	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	43.3	46.6	-3.31	AORT	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	98.3x	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$1.22B	$1.14B	$80.6M	DRTS	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	DRTS REV	AORT REV	DRTS GROSS %	AORT GROSS %	DRTS FCF	AORT FCF
FY 2025	$0	$441.3M	—	64.4%	-$32.8M	$839.0K
FY 2024	$0	$388.5M	—	64.0%	-$22.0M	$11.0M
FY 2023	$0	$354.0M	—	—	-$18.0M	$18.8M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

DRTS // BETA —

AORT // BETA —